Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription Articles published in JAMA Retrieve available abstracts of 45 articles: HTML format

Single Articles

January 2026
1. ROSE MR, Flexner C, Roy V
   Subscription-Based Pricing for Lenacapavir-Learning From Hepatitis C and Cabotegravir.
   JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.24404.
   PubMed    
   
   
   December 2025
2. PERSON AK, Kelley CF
   World AIDS Day-At a Crossroads.
   JAMA. 2025 Dec 1. doi: 10.1001/jama.2025.23506.
   PubMed    
   
   
   
3. TU SS, Bonis T, Sinha MS, Slade DH, et al
   Combination-Only Approvals as a Barrier to Affordable HIV Care.
   JAMA. 2025 Dec 1. doi: 10.1001/jama.2025.21935.
   PubMed    
   
   
   November 2025
4. HSU M, Shah A, Jordan A, Gold MS, et al
   Therapeutic Use of Cannabis and Cannabinoids: A Review.
   JAMA. 2025 Nov 26. doi: 10.1001/jama.2025.19433.
   PubMed     Abstract available
   
   
   
5. MAUERMANN ML, Staff NP
   Peripheral Neuropathy: A Review.
   JAMA. 2025 Nov 17. doi: 10.1001/jama.2025.19400.
   PubMed     Abstract available
   
   
   October 2025
6. CHEVALIER FJ, Bacon O, Johnson KA, Cohen SE, et al
   Syphilis: A Review.
   JAMA. 2025 Oct 16. doi: 10.1001/jama.2025.17362.
   PubMed     Abstract available
   
   
   September 2025
7. ASSOUMOU SA, Alexander RN, Miller SE
   Viral Infections Associated With Injection Drug Use.
   JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.13287.
   PubMed    
   
   
   August 2025
8. ANDERER S
   Measles Resurgence Puts People With HIV at Risk.
   JAMA. 2025 Aug 22. doi: 10.1001/jama.2025.11011.
   PubMed    
   
   
   
9. CHAN PA, Nunn AS
   Grant Terminations in the US Threaten HIV Research and Future Progress.
   JAMA. 2025 Aug 21. doi: 10.1001/jama.2025.12688.
   PubMed    
   
   
   
10. ANDERER S
    WHO Recommends Lenacapavir for HIV Prevention in New Guidelines.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.10988.
    PubMed    
    
    
    July 2025
11. ANDERER S
    FDA Approves First Twice-Yearly PrEP for Long-Acting HIV Prevention.
    JAMA. 2025 Jul 11. doi: 10.1001/jama.2025.10325.
    PubMed    
    
    
    
12. MARKS KM, Kang M, Umbleja T, Cox A, et al
    HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.
    JAMA. 2025 Jul 2:e259894. doi: 10.1001/jama.2025.9894.
    PubMed    
    
    
    
13. COLLINS LF, Cunningham SA, Vaughan CP, Ofotokun I, et al
    Promoting Healthy Aging in People With HIV-Into a New Era.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.9244.
    PubMed    
    
    
    June 2025
14. LANDOVITZ RJ, Molina JM, Buchbinder SP
    Preexposure Prophylaxis for HIV: Updated Recommendations From the 2024 International Antiviral Society-USA Panel.
    JAMA. 2025 Jun 27. doi: 10.1001/jama.2025.11410.
    PubMed    
    
    
    May 2025
15. MAGHSOUDLOU P, Epps SJ, Guly CM, Dick AD, et al
    Uveitis in Adults: A Review.
    JAMA. 2025 May 28. doi: 10.1001/jama.2025.4358.
    PubMed     Abstract available
    
    
    
16. EHRENKRANZ PD, Reid MJA, Doherty M, Kim PS, et al
    Long-Acting HIV Treatment in Low- and Middle-Income Countries: Addressing the Public Health Need.
    JAMA. 2025 May 19. doi: 10.1001/jama.2025.5180.
    PubMed    
    
    
    
17. ANDERER S
    One Million New Pediatric HIV Cases Predicted If PEPFAR Funding Is Cut.
    JAMA. 2025 May 9. doi: 10.1001/jama.2025.6155.
    PubMed    
    
    
    April 2025
18. ANDERER S
    Cuts to HIV Assistance Could Undo Years of Progress.
    JAMA. 2025 Apr 25. doi: 10.1001/jama.2025.4672.
    PubMed    
    
    
    March 2025
19. SPINELLI MA, Heise MJ, Gistand N, Cox C, et al
    HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia.
    JAMA. 2025 Mar 6. doi: 10.1001/jama.2025.0109.
    PubMed    
    
    
    February 2025
20. SEAS C, Seas PR, Legua P
    A 25-Year-Old With Verrucous Pustules and Fevers.
    JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.28032.
    PubMed    
    
    
    
21. APPA A, Spinelli MA, Javanbakht M, Heise MJ, et al
    Unintentional Fentanyl Use Detected in Hair of People With HIV Risk Using Methamphetamine.
    JAMA. 2025 Feb 26:e2428618. doi: 10.1001/jama.2024.28618.
    PubMed    
    
    
    January 2025
22. ANDERER S
    Twice-Yearly Lenacapavir Could Support HIV Prevention in Vulnerable Populations.
    JAMA. 2025 Jan 3. doi: 10.1001/jama.2024.26876.
    PubMed    
    
    
    December 2024
23. DEL RIO C, Dzau V
    The Urgent Case for Recommitting to Global HIV/AIDS Goals.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26348.
    PubMed    
    
    
    
24. GANDHI RT, Landovitz RJ, Sax PE, Smith DM, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24543.
    PubMed     Abstract available
    
    
    
25. MARKS KM, Kang M, Umbleja T, Cox A, et al
    HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
    JAMA. 2024 Dec 1:e2424490. doi: 10.1001/jama.2024.24490.
    PubMed     Abstract available
    
    
    
26. HATLEN TJ, Bender Ignacio R, Daar ES
    Advances in Treatment and Prevention of HIV.
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24027.
    PubMed    
    
    
    
27. NIU X, Drain PK
    Is Lenacapavir Needed for Individuals Adherent to Daily Oral PrEP?
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.22995.
    PubMed    
    
    
    October 2024
28. PALEFSKY JM
    Prevention of Anal Cancer in High-Risk Individuals.
    JAMA. 2024 Oct 23. doi: 10.1001/jama.2024.17870.
    PubMed    
    
    
    
29. MANN LM, Zhu W, Huang YA, Kourtis AP, et al
    Trends in Oral and Injectable HIV Preexposure Prophylaxis Prescriptions in the US, 2013-2023.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21493.
    PubMed    
    
    
    
30. TITANJI BK, Hazra A, Zucker J
    Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21091.
    PubMed     Abstract available
    
    
    
31. SPINELLI MA, Ngure K, Gandhi M
    Preexposure Prophylaxis (PrEP) for HIV.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.16984.
    PubMed    
    
    
    September 2024
32. MALANI P
    Thirty-Five Years of HIV Research in Africa-An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award.
    JAMA. 2024 Sep 19. doi: 10.1001/jama.2024.19030.
    PubMed    
    
    
    July 2024
33. SCHRIER E, Schwartz HEM, Himmelstein DU, Gaffney A, et al
    Hospital Assets Before and After Private Equity Acquisition.
    JAMA. 2024 Jul 30:e2413555. doi: 10.1001/jama.2024.13555.
    PubMed    
    
    
    June 2024
34. HARRIS E
    AAP Changes Its Breastfeeding Policy for People With HIV in US.
    JAMA. 2024 Jun 14. doi: 10.1001/jama.2024.10335.
    PubMed    
    
    
    
35. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed     Abstract available
    
    
    May 2024
36. HARRIS E
    CDC Warns of Surge in Meningococcal Disease in US.
    JAMA. 2024;331:1614.
    PubMed    
    
    
    
37. MCKENNA M
    Produce Prescriptions Sound Good, but Data to Support Them Are Lacking-That Could Soon Change.
    JAMA. 2024;331:1433-1436.
    PubMed    
    
    
    April 2024
38. HARRIS E
    WHO Documents Rising Resistance to First-Line HIV Drug.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4497.
    PubMed    
    
    
    March 2024
39. STOOPLER ET, Villa A, Bindakhil M, Diaz DLO, et al
    Common Oral Conditions: A Review.
    JAMA. 2024;331:1045-1054.
    PubMed     Abstract available
    
    
    
40. SHETH AN, Momplaisir F, Dumond JB
    Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    JAMA. 2024;331:912-914.
    PubMed    
    
    
    
41. PECK RN, Issarow B, Kisigo GA, Kabakama S, et al
    Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial.
    JAMA. 2024 Mar 6:e242177. doi: 10.1001/jama.2024.2177.
    PubMed     Abstract available
    
    
    
42. AMICO KR
    A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at Minimal Cost.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.0271.
    PubMed    
    
    
    
43. HARRIS E
    Long-Acting HIV Treatment Superior to Daily Oral Drugs.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1570.
    PubMed    
    
    
    
44. MARRAZZO J, Tao L, Becker M, Leech AA, et al
    HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.0464.
    PubMed     Abstract available
    
    
    
45. SAX PE, Thompson MA, Saag MS
    Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.2985.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.